Kumar, Pavitra
Hassan, Mohsin
Tacke, Frank
Engelmann, Cornelius http://orcid.org/0000-0002-8233-2273
Funding for this research was provided by:
Deutsche Forschungsgemeinschaft (403224013)
Berlin Institute of Health (BIH)
European Association for the Study of the Liver (Sheila Sherlock Post-graduate Fellowship-2021)
Charité - Universitätsmedizin Berlin
Article History
Received: 24 October 2023
Revised: 11 March 2024
Accepted: 7 April 2024
First Online: 30 April 2024
Declarations
:
: CE received advisory fees from Novartis, Albireo/lpsen, Gilead and CSL Behring. CE is a shareholder of the UCL Spin-out Company Hepyx. FT received research grants from Gilead, Allergan, Bristol-Myers Squibb, and Inventiva.
: All animal experiments complied with ethical regulations and were approved by the committee on Research Animal Care of the Charité—Universitätsmedizin Berlin, Berlin, Germany (License number: G0174/20). There were no human samples involved in this work.
: All authors reviewed the results and contributed to the final manuscript. All authors approved this manuscript for publication.